FindTrial
Sign In

Iocide Oral Rinse

DRUG2 trials

Sponsors

Biomedical Development Corporation

Conditions

GingivitisInvestigation of Biological Markers of Inflammation

Phase 2

Dose-Response Study of Iocide Oral Rinse
CompletedNCT01103102
Biomedical Development CorporationGingivitis
Start: 2010-04-30End: 2012-04-30Updated: 2013-01-29
Efficacy of Iocide Oral Rinse Against Gingival Inflammation
NCT01782170
Biomedical Development CorporationGingivitis, Investigation of Biological Markers of Inflammation
Start: 2013-02-28End: 2014-05-31Target: 76Updated: 2013-08-14